Jillian Clare Kohler

Summary

Affiliation: University of Toronto
Country: Canada

Publications

  1. doi request reprint Why the MDGs need good governance in pharmaceutical systems to promote global health
    Jillian Clare Kohler
    Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College Street, Toronto M5S 3 M2, ON, Canada
    BMC Public Health 14:63. 2014
  2. pmc "To patent or not to patent? the case of Novartis' cancer drug Glivec in India"
    Ravinder Gabble
    Associate Professor and Director Global Health, Leslie Dan Faculty of Pharmacy, and Munk School of Global Affairs, University of Toronto, 144 College Street, Toronto, Ontario M5S 3 M2, Canada
    Global Health 10:3. 2014
  3. pmc Corruption in the health care sector: A barrier to access of orthopaedic care and medical devices in Uganda
    Maryse Bouchard
    Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada
    BMC Int Health Hum Rights 12:5. 2012
  4. pmc An examination of pharmaceutical systems in severely disrupted countries
    Jillian Clare Kohler
    Associate Professor, Leslie Dan Faculty of Pharmacy and Munk School of Global Affairs, University of Toronto, Toronto, Canada
    BMC Int Health Hum Rights 12:34. 2012
  5. pmc Framing access to medicines in developing countries: an analysis of media coverage of Canada's Access to Medicines Regime
    Laura C Esmail
    Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College Street, Toronto, Ontario, Canada
    BMC Int Health Hum Rights 10:1. 2010
  6. pmc Exploring consumer and pharmacist views on the professional role of the pharmacist with respect to natural health products: a study of focus groups
    Della Kwan
    1Department of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Toronto, Canada
    BMC Complement Altern Med 8:40. 2008
  7. doi request reprint Addressing legal and political barriers to global pharmaceutical access: options for remedying the impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the imposition of TRIPS-plus standards
    Jillian Clare Cohen-Kohler
    Leslie Dan Faculty of Pharmacy, University of Toronto, Canada
    Health Econ Policy Law 3:229-56. 2008
  8. ncbi request reprint The morally uncomfortable global drug gap
    J C Cohen-Kohler
    Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
    Clin Pharmacol Ther 82:610-4. 2007
  9. pmc The politics behind the implementation of the WTO Paragraph 6 Decision in Canada to increase global drug access
    Laura C Esmail
    Leslie Dan Faculty of Pharmacy, Toronto, ON, Canada
    Global Health 8:7. 2012
  10. pmc The use of cost-effectiveness analysis for pediatric immunization in developing countries
    Cindy Low Gauvreau
    St Michael s Hospital, Toronto, Canada
    Milbank Q 90:762-90. 2012

Collaborators

Detail Information

Publications12

  1. doi request reprint Why the MDGs need good governance in pharmaceutical systems to promote global health
    Jillian Clare Kohler
    Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College Street, Toronto M5S 3 M2, ON, Canada
    BMC Public Health 14:63. 2014
    ..This discussion on the pharmaceutical system illuminates why...
  2. pmc "To patent or not to patent? the case of Novartis' cancer drug Glivec in India"
    Ravinder Gabble
    Associate Professor and Director Global Health, Leslie Dan Faculty of Pharmacy, and Munk School of Global Affairs, University of Toronto, 144 College Street, Toronto, Ontario M5S 3 M2, Canada
    Global Health 10:3. 2014
    ..Indeed, the Supreme Court stated that even if the bioavailability of the drug was improved, it did not demonstrate enhanced efficacy and that Glivec was not patentable...
  3. pmc Corruption in the health care sector: A barrier to access of orthopaedic care and medical devices in Uganda
    Maryse Bouchard
    Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada
    BMC Int Health Hum Rights 12:5. 2012
    ..abstract:..
  4. pmc An examination of pharmaceutical systems in severely disrupted countries
    Jillian Clare Kohler
    Associate Professor, Leslie Dan Faculty of Pharmacy and Munk School of Global Affairs, University of Toronto, Toronto, Canada
    BMC Int Health Hum Rights 12:34. 2012
    ..Counterfeit and sub-standard medicines trade networks have also developed. To help increase medicine availability for citizens, informal markets should be integrated into existing access to medicines initiatives...
  5. pmc Framing access to medicines in developing countries: an analysis of media coverage of Canada's Access to Medicines Regime
    Laura C Esmail
    Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College Street, Toronto, Ontario, Canada
    BMC Int Health Hum Rights 10:1. 2010
    ..The purpose of this study was to examine how the media framed CAMR to determine how policy goals were conceptualized, which stakeholder interests controlled the public debate and how these variables related to the public policy process...
  6. pmc Exploring consumer and pharmacist views on the professional role of the pharmacist with respect to natural health products: a study of focus groups
    Della Kwan
    1Department of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Toronto, Canada
    BMC Complement Altern Med 8:40. 2008
    ..In this paper, consumers' and practicing pharmacists' perceptions of pharmacists' professional responsibilities with respect to NHPs are examined...
  7. doi request reprint Addressing legal and political barriers to global pharmaceutical access: options for remedying the impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the imposition of TRIPS-plus standards
    Jillian Clare Cohen-Kohler
    Leslie Dan Faculty of Pharmacy, University of Toronto, Canada
    Health Econ Policy Law 3:229-56. 2008
    ....
  8. ncbi request reprint The morally uncomfortable global drug gap
    J C Cohen-Kohler
    Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
    Clin Pharmacol Ther 82:610-4. 2007
    ..2, 3) But governments also have to ensure that the policy environment is supportive of access to medicines. And this includes making sure that social policy is not undercut by economic interests...
  9. pmc The politics behind the implementation of the WTO Paragraph 6 Decision in Canada to increase global drug access
    Laura C Esmail
    Leslie Dan Faculty of Pharmacy, Toronto, ON, Canada
    Global Health 8:7. 2012
    ..Since it was passed in 2004, only two orders of antiretroviral drugs, enough for 21,000 HIV/AIDS patients in Rwanda have been exported. Future use of the regime appears unlikely. This research aimed to examine the politics of CAMR...
  10. pmc The use of cost-effectiveness analysis for pediatric immunization in developing countries
    Cindy Low Gauvreau
    St Michael s Hospital, Toronto, Canada
    Milbank Q 90:762-90. 2012
    ..Cost-effectiveness analysis (CEA) is a tool that decision makers can use for efficiently allocating expanding resources. Its use in developing countries, however, lags behind that in industrialized countries...
  11. pmc The make or buy debate: considering the limitations of domestic production in Tanzania
    Kinsley Rose Wilson
    Leslie Dan Faculty of Pharmacy and Munk School of Global Affairs, University of Toronto, 144 College Street, Toronto, M5S 3M2, Canada
    Global Health 8:20. 2012
    ..In order for domestic manufacturing to be viable and cost-effective, the local industry must be able to compete with international suppliers of medicines by producing sufficiently low cost ARVs...